Skip to content

Drug interactions

Fingolimod + Pimavanserin

Severity: Major

Fingolimod and Pimavanserin: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pimavanserin prolongs the QT interval, and fingolimod can cause bradycardia and has been linked to QT effects. The combination may increase the risk of ventricular arrhythmia.

What this interaction means in plain words

Fingolimod and Pimavanserin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Fingolimod belongs to Central Nervous System; Pimavanserin belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive effects on cardiac repolarisation with fingolimod-related bradycardia.

What to do

Avoid if a suitable alternative exists. If combined, check baseline ECG, correct electrolytes and monitor QTc and heart rate.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fingolimod and Pimavanserin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fingolimod with Pimavanserin?

MediHelp rates the interaction as major. Fingolimod and Pimavanserin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pimavanserin prolongs the QT interval, and fingolimod can cause bradycardia and has been linked to QT effects. The combination may increase the risk of ventricular arrhythmia.

How serious is the interaction between Fingolimod and Pimavanserin?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if a suitable alternative exists. If combined, check baseline ECG, correct electrolytes and monitor QTc and heart rate.

What other medicines interact with Fingolimod?

MediHelp also lists interactions of Fingolimod with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Pimozide. The full list is on the Fingolimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in